Actively Recruiting
RACE-2L: Real-World Assessment of Clinical Practice and Outcomes in Non-squamous NSCLC After Failure of Platinum-based Chemotherapy in Brazil
Led by AstraZeneca · Updated on 2026-04-21
250
Participants Needed
11
Research Sites
100 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The study will be implemented as a retrospective, noninterventional medical record review of patients from routine practice settings who have been diagnosed with a/m non-squamous NSCLC with or without AGA and received at least 1 line of systemic treatment after failing PTC between January 2017 and December 2024.
CONDITIONS
Official Title
RACE-2L: Real-World Assessment of Clinical Practice and Outcomes in Non-squamous NSCLC After Failure of Platinum-based Chemotherapy in Brazil
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Confirmed diagnosis of non-squamous NSCLC stage IIIB/IIIC not eligible for curative therapies or stage IV/M1 (advanced/metastatic NSCLC) with or without actionable genomic mutations
- Age 18 years or older at first diagnosis of advanced/metastatic NSCLC
- For patients with actionable genomic alterations (AGA), must have received platinum-based chemotherapy and at least one approved targeted therapy
- For patients without AGA, must have received either sequential or concurrent immunotherapy and platinum-based chemotherapy
- Must have received at least one line of therapy with an active agent after failing platinum-based chemotherapy
You will not qualify if you...
- Evidence of other primary cancers (except basal cell carcinoma and melanoma) within 1 year before the study start date
- Participation in any investigational cancer treatment trial or early access program from 2018 onward
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 11 locations
1
Research Site
Belo Horizonte, Minas Gerais, Brazil, 30110-934
Not Yet Recruiting
2
Research Site
Belo Horizonte, Minas Gerais, Brazil, 30380-420
Not Yet Recruiting
3
Research Site
Natal, Rio Grande do Norte, Brazil, 59062-000
Actively Recruiting
4
Research Site
Porto Alegre, Rio Grande do Sul, Brazil, 90560-032
Not Yet Recruiting
5
Research Site
São José do Rio Preto, São Paulo, Brazil, 15090-000
Not Yet Recruiting
6
Research Site
São Paulo, Brazil, 01308-050
Actively Recruiting
7
Research Site
São Paulo, Brazil, 01323-001
Not Yet Recruiting
8
Research Site
São Paulo, Brazil, 01323-020
Actively Recruiting
9
Research Site
São Paulo, Brazil, 01333-010
Actively Recruiting
10
Research Site
São Paulo, Brazil, 01509-010
Not Yet Recruiting
11
Research Site
São Paulo, Brazil, 05652-900
Actively Recruiting
Research Team
A
AstraZeneca Clinical Study Information Center
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here